According to Bayer AG, more than 80% of consumers globally want more personalized health care and want tools to help them predict and prevent illness along with better tools to manage their health.
‘Faster, Better, More Efficient’ – Why Bayer Is Investing In ‘Precision Health’
Like other big global OTC players, Bayer Consumer Health is stepping up its investment in digital self-care. In the first part of an exclusive interview, HBW Insight catches up with the company's head of R&D and chief scientific officer David Evendon-Challis to dig deeper into the rationale for setting up a new 'prescision health' business unit, including why a holistic and personalized approach to digital self-care increases trust in long-loved and science-backed brands.
